IC
Ikarian Capital, LLC cut its QNRX stake below 5%
Ikarian Capital, LLC reported owning 4.4% of Quoin Pharmaceuticals Ltd. (QNRX) (211,538 shares) in a Schedule 13G filed Oct 7, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Oct 7, 2026
- Source
- Schedule 13G